Categories
Drug Coated Balloon
Stenting of popliteal lesions performs superior to drug coated balloon angioplasty
Karim Salem, MD | 2020 Annual Meeting
Are the Reported Advantages of Pacitaxil Therapy worth the potential risks?
Darren Schneider, MD | 2020 Annual Meeting
Paclitaxel: Friend or Foe…Data Driven Decision Making (Sponsored by Boston Scientific)
Michael Jaff, DO | 2020 Annual Meeting
Propensity-Matched Analysis of Patients Treated with Paclitaxel-Coated Versus Uncoated Balloons
Alexander King, MS | 2020 Annual Meeting
Drug Coated Balloon Angioplasty Confers No Advantage In The Treatment Of Femoropopliteal Disease When Stenting Is Required
Kathleen Ozsvath, MD | 2018 Annual Meeting
Nationwide Trends in Drug-Coated Balloon and Drug-Eluting Stent Utilization in the Femoropopliteal Arteries
Abhisekh Mohapatra, MD | 2018 Annual Meeting